Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

doi:10.1186/1750-9378-4-S2-O2

Infectious Agents and Cancer

Volume 4
Suppl 2

Viewing options:

Abstract
Full text
PDF (132KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Bohlius J

on PubMed

Bohlius J
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research .

Oral presentation

Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

J Bohlius¹^,2

¹for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group

²Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

corresponding author email

from 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Bethesda, MD, USA. 6–7 October 2008

Infectious Agents and Cancer 2009, 4(Suppl 2):O2doi:10.1186/1750-9378-4-S2-O2


Published:	17 June 2009

First paragraph (this article has no abstract)

Incidence and risk factors of HIV-associated non-Hodgkin lymphoma (NHL) in the era of combined anti-retroviral therapy (cART) have not been well defined. We analyzed incidence and risk factors for HIV-related NHL in the era of cART within the framework of a large European multi-cohort collaborative study.